835 results match your criteria: "university of Paris Saclay[Affiliation]"

BACKGROUND: Prostate cancer is regulated by steroid hormones, even in castration-resistant disease. ODM-208, a novel inhibitor of cytochrome P450 11A1 (which catalyzes the first step of steroid-hormone biosynthesis), was investigated in patients with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC). METHODS: CYPIDES is a first-in-human phase 1 (3 + 3 design) and phase 2 study.

View Article and Find Full Text PDF
Article Synopsis
  • A first-in-human study was conducted to evaluate the safety and efficacy of acapatamab, a bispecific T-cell engager targeting metastatic castration-resistant prostate cancer (mCRPC).
  • 133 patients participated, receiving varying doses of acapatamab; the most common side effect was cytokine release syndrome (CRS), noted in a large majority, particularly during the first treatment cycle.
  • Preliminary results showed some antitumor activity, with 30.4% of patients experiencing confirmed PSA responses, though the overall durable activity was limited and further evaluation is needed.
View Article and Find Full Text PDF

Introduction: Dietary intake of (poly)phenols has been linked to reduced adiposity and body weight (BW) in several epidemiological studies. However, epidemiological evidence on (poly)phenol biomarkers, particularly plasma concentrations, is scarce. We aimed to investigate the associations between plasma (poly)phenols and prospective BW change in participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

View Article and Find Full Text PDF

Background: To date, limited evidence exists on the impact of COVID-19 in patients with soft tissue sarcoma (STS), nor about the impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in this specific population.

Methods: We described COVID-19 morbidity and mortality among patients with STS across 'Omicron' (15 December 2021-31 January 2022), 'Pre-vaccination' (27 February 2020-30 November 2020), and 'Alpha-Delta' phase (01 December 2020-14 December 2021) using OnCovid registry participants (NCT04393974). Case fatality rate at 28 days (CFR) and COVID-19 severity were also described according to the SARS-CoV-2 vaccination status, while the impact of the receipt of cytotoxic chemotherapy within 4 weeks prior to COVID-19 on clinical outcomes was assessed with Inverse Probability of Treatment Weighting (IPTW) models adjusted for possible confounders.

View Article and Find Full Text PDF

Introduction: The motor subtypes of Parkinson's disease (PD) are widely accepted and implemented. However, the motor subtypes have been thought to represent different stages of PD recently because some patients experience tremor-dominant (TD) conversion to the non-tremor-dominant subtype, such as postural instability-gait difficulty (PIGD). In this study, we explore the monoaminergic denervation features of the striatal and extra-striatal areas in patients with different subtypes of PD with F-9-fluoropropyl-(+)-dihydrotetrabenazine (F-FP-DTBZ) PET/CT.

View Article and Find Full Text PDF

Purpose: GEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who previously received 5-fluorouracil, oxaliplatin, and irinotecan.

Methods: Patients with histologically or cytologically confirmed mPDAC were randomly assigned (2:1) to receive GEMPAX (paclitaxel 80 mg/m + gemcitabine 1,000 mg/m; IV; once at day (D) 1, D8, and D15/arm A) or gemcitabine (arm B) alone once at D1, D8, and D15 every 28 days until progression, toxicity, or patient's decision. The primary end point was overall survival (OS).

View Article and Find Full Text PDF

Interim analysis of the DOSISPHERE-01 study demonstrated a strong improvement in response and overall survival (OS) on using Y-loaded glass microspheres with personalized dosimetry compared with standard dosimetry in patients with nonoperable locally advanced hepatocellular carcinoma. This report sought to provide a long-term analysis of OS. In this phase II study (ClinicalTrials.

View Article and Find Full Text PDF

Sunitinib Treatment of VHL C162F Cells Slows Down Proliferation and Healing Ability via Downregulation of ZHX2 and Confers a Mesenchymal Phenotype.

Cancers (Basel)

December 2023

INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France.

von Hippel-Lindau (VHL) disease, due to mutations of the tumor suppressor gene, is a rare hereditary syndrome with a high risk of developing clear cell renal cell carcinoma (ccRCC). We asked whether the VHL-C162F mutation interferes with proliferation, migration, healing and forming colony ability by using wild-type (WT VHL) and VHL-C162F reconstituted cells. We then analyzed the in vitro impact of the sunitinib treatment on VHL-C162F cells.

View Article and Find Full Text PDF

Background: In patients with infectious diseases, remote consultation (RC) may be questionable compared with face-to-face office consultation (OC), not only because of the lack of physical examination but also because of the risk of overprescribing antibiotics (ATBs).

Aim: To analyse ATB prescription in OC versus RC in a sample of French GPs.

Design & Setting: This is a retrospective observational cohort study in general practice in 2021.

View Article and Find Full Text PDF

Objective: To determine the impact of the SARS-CoV-2 (COVID-19) pandemic and lockdowns on the mental health status, training, perceptions of the physiotherapy profession, and career plans of French physiotherapy students.

Design: A descriptive cross-sectional study was conducted, representing the first and only survey of its kind, using a national online survey.

Subjects: A total of 2678 French physiotherapy students participated in the study.

View Article and Find Full Text PDF

Background: Hemophilia A (HA) is predominantly associated with males due to X-linked inheritance. Males and females with HA have shared unmet medical needs, highlighting the necessity for comprehensive care irrespective of sex.

Objectives: This analysis investigated the efficacy and safety of emicizumab prophylaxis in 3 females with HA.

View Article and Find Full Text PDF

Background And Objective: [Lu]Lu-PSMA-617 (Lu-PSMA-617) plus the standard of care (SoC) significantly improved overall survival and radiographic progression-free survival versus SoC alone in patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer in the VISION trial. We evaluated the safety of additional cycles of Lu-PSMA-617 and the impact of longer observation time for patients receiving Lu-PSMA-617 plus SoC.

Methods: VISION was an international, open-label study.

View Article and Find Full Text PDF
Article Synopsis
  • Bicycloalkanes and cubanes are becoming important alternatives to traditional (hetero)arenes in the chemical field, prompting new synthetic methods.
  • This review evaluates advancements in using light-driven techniques for creating and modifying these unique structures, focusing on specific targets like bicyclopentanes, bicyclohexanes, and cubanes.
  • The article concludes by exploring future avenues for discovering new reactions that can generate functionalized bioisosteric compounds.
View Article and Find Full Text PDF

Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.

Schizophr Res

February 2024

Fondation Fondamental, Créteil, France; Université de Paris, INSERM UMR1266, Institute of Psychiatry and Neuroscience of Paris, France; AP-HP, Department of Psychiatry, Louis Mourier Hospital, Colombes, France.

Background: Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD in schizophrenia and the clinical and cognitive characteristics associated with C-ADHD history in schizophrenia.

Methods: 569 subjects with schizophrenia (74 % men, mean age 30.

View Article and Find Full Text PDF

The aims of this study in elite youth French players were to 1) describe the anthropometric and physical characteristics of international and non-international players from U16 to U20, and 2) compare these characteristics across age categories and playing standard (international or non-international). Altogether, 1423 players from the French Rugby Federation's academies participated in a physical testing battery, part of its national young player development pathway. From seasons 2010 to 2020, players were assessed for anthropometric (body mass and height), off-field (bench press; isometric squat, vertical jump) and on-field physical characteristics (aerobic capacity: maximal aerobic speed [MAS]; speed: 10-m, 50-m sprint).

View Article and Find Full Text PDF

Background: Proton pump inhibitors (PPIs) are largely used in older adults and data are needed in off-label indications, such as the prevention of upper gastrointestinal bleeding (UGIB) in patients receiving oral anticoagulants (OACs). This study aimed to assess whether PPIs reduce the risk of UGIB in patients initiating oral anticoagulation.

Methods: We conducted a longitudinal study based on the French national health database.

View Article and Find Full Text PDF

Purpose: MP2RAGE parameter optimization is redefined to allow more time-efficient MR acquisitions, whereas the T -based synthetic imaging framework is used to obtain on-demand T -weighted contrasts. Our aim was to validate this concept on healthy volunteers and patients with multiple sclerosis, using plug-and-play parallel-transmission brain imaging at 7 T.

Methods: A "time-efficient" MP2RAGE sequence was designed with optimized parameters including TI and TR set as small as possible.

View Article and Find Full Text PDF

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.

Prostate Cancer Prostatic Dis

September 2024

Istituto Oncologico della Svizzera Italiana, EOC, Bellinzona, Switzerland.

Article Synopsis
  • Darolutamide is an androgen receptor pathway inhibitor for prostate cancer, and its toxicity profile is a crucial factor for treatment selection, although efficacy among different ARPIs appears similar.
  • A systematic review and meta-analysis were conducted using data from clinical trials comparing darolutamide to placebo, focusing on adverse events (AEs) that could lead to treatment discontinuation.
  • The results showed that darolutamide did not significantly increase AEs compared to placebo, except for a notable higher incidence of bone fractures associated with placebo.
View Article and Find Full Text PDF

Background: Prior work from the Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP) consortium (ICECaP-1) demonstrated that metastasis-free survival (MFS) is a valid surrogate for overall survival (OS) in localized prostate cancer (PCa). This was based on data from patients treated predominantly before 2004, prior to docetaxel being available for the treatment of metastatic castrate-resistant prostate cancer (mCRPC). We sought to validate surrogacy in a more contemporary era (ICECaP-2) with greater availability of docetaxel and other systemic therapies for mCRPC.

View Article and Find Full Text PDF
Article Synopsis
  • Preclinical studies indicate a link between the androgen receptor and poly(ADP-ribose) polymerase in prostate cancer, suggesting that inhibiting both may effectively treat metastatic castration-resistant prostate cancer (mCRPC).
  • The TALAPRO-2 phase 3 study compared the effects of combining talazoparib (a poly(ADP-ribose) polymerase inhibitor) with enzalutamide against enzalutamide alone, specifically focusing on patients with DNA damage response gene alterations.
  • Results showed that the combination therapy significantly extended radiographic progression-free survival for patients with homologous recombination repair (HRR) deficiencies, with the talazoparib group not reaching median survival at the time of
View Article and Find Full Text PDF

Automatic Detection of AMD and DME Retinal Pathologies Using Deep Learning.

Int J Biomed Imaging

November 2023

Laboratory of Biophysics and Medical Technologies, Higher Institute of Medical Technologies of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Diabetic macular edema (DME) and age-related macular degeneration (AMD) are two common eye diseases. They are often undiagnosed or diagnosed late. This can result in permanent and irreversible vision loss.

View Article and Find Full Text PDF